TTTehreem Talab

Tehreem Talab

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tehreem Talab has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Therapeutic equivalence of intermittent and continuous phototherapy for neonatal jaundice: a systematic review & meta-analysis with regression and trial sequential analysis

    by Fahad Amin, Rija Fatima, Saira Iqbal, Abdul Rehman Azam, Tehreem Talab, Taimoor Hassan, Esha Naeem, Muhammad Talha, Mashal Zahid, Hurain Naeem

    Phototherapy is the mainstay treatment for neonatal hyperbilirubinemia, but the optimal delivery strategy remains debated. Intermittent phototherapy (IMPT) has been proposed as an alternative to continuous phototherapy (CPT) that may achieve comparable bilirubin reduction with fewer adverse effects. This systematic review and meta-analysis evaluated the comparative efficacy and safety of IMPT versus CPT in neonates with hyperbilirubinemia. PubMed, Embase, Scopus, Cochrane Library, and ClinicalTrials.gov were searched through June 2026 for randomized controlled trials comparing IMPT and CPT. Outcomes included rate of fall in bilirubin, follow-up bilirubin, phototherapy duration, hospital stay, and mortality. Random-effects meta-analysis pooled mean differences (MD) and risk ratios (RR) with 95% confidence intervals (CI). Subgroup, meta-regression, and Trial Sequential Analysis (TSA) were performed, and certainty of evidence was graded using GRADE. Twenty-six RCTs (3,891 neonates) were included. No significant difference was found between IMPT and CPT for rate of bilirubin fall, follow-up bilirubin, hospital stay, or mortality. IMPT significantly reduced phototherapy duration (MD - 10.40 h, 95% CI - 18.91 to - 1.88). Heterogeneity was substantial across outcomes. TSA indicated conclusive evidence of equivalence for bilirubin-related and hospital stay outcomes, while evidence for the duration reduction had not yet reached the required information size. Certainty of evidence ranged from low to very low. IMPT achieves outcomes comparable to CPT while significantly reducing treatment duration, supporting its use as a time-efficient alternative, though findings warrant cautious interpretation given low certainty of evidence. • IMPT and CPT show comparable bilirubin reduction, but prior comparisons relied on limited trials without assessing whether the evidence base is conclusive. • This review incorporates the latest trials, applies Cochrane-guided meta-regression, subgroup, leave-one-out, and Hartung-Knapp sensitivity analyses, and uses TSA to confirm conclusive equivalence across major outcomes.


  • Efficacy and safety of papillary vs non-papillary access to the calyces in patients undergoing percutaneous lithotripsy: a GRADE-assessed systematic review and meta-analysis

    by Fahad Amin, Ammad Abid, Waleeja Rehaam, Tehreem Talab, Faheem Ullah, Zainab Saleem, Mahnoor Sultana, Abu-Bakr Ahmed

    Background Percutaneous nephrolithotomy (PCNL) access is traditionally obtained via papillary puncture to minimize bleeding, though non-papillary access is frequently utilized in everyday clinical practice due to practical considerations such as anatomical variations and stone location. Because existing comparative studies have yielded inconsistent findings, this systematic review and meta-analysis aimed to synthesize existing evidence evaluating the safety and efficacy of papillary versus non-papillary access during PCNL. Methods A comprehensive systematic search of databases, including PubMed, Embase, the Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov, alongside grey literature, was conducted from inception until December 2025. Randomized controlled trials and observational studies comparing papillary and non-papillary access for renal calculi in patients undergoing PCNL were included. Data were pooled using a random-effects model to calculate mean differences (MD) and odds ratios (OR) alongside their 95% confidence intervals (CIs). Results A total of six studies comprising 856 patients met the inclusion criteria. Pooled analyses demonstrated no statistically significant differences between the papillary and non-papillary access groups regarding hemoglobin drop (MD 0.09 g/dL, 95% CI -0.19 to 0.37), transfusion rates (OR 1.28, 95% CI 0.59 to 2.74), changes in postoperative serum creatinine levels (MD 0.02 mg/dL, 95% CI -0.03 to 0.07), duration of hospital stay (MD 0.08 days, 95% CI -0.28 to 0.44), stone-free status (OR 1.20, 95% CI 0.76 to 1.89), or operative duration (MD 2.81 min, 95% CI -2.06 to 7.68). Heterogeneity across most outcomes was minimal. Meta-regression identified stone size as the only significant moderator, which negatively influenced operative duration. Conclusion Papillary and non-papillary access techniques during PCNL appear to provide comparable clinical outcomes with no significant differences in major perioperative parameters. The clinical decision-making regarding the selection of access technique should be individualized, considering patient anatomy, stone characteristics, and surgical expertise rather than strict adherence to a single standardized puncture strategy.